Apex Science & Engineering Corp. (TPE:3052)
Taiwan · Delayed Price · Currency is TWD 11.60
+0.10 (0.87%)
Feb 11, 2026, 1:30 PM CST
TPE:3052 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 3,281 | 2,660 | 3,484 | 2,952 | 3,615 | 5,218 | |
Revenue Growth (YoY) | 7.17% | -23.66% | 18.04% | -18.34% | -30.72% | -7.22% |
Cost of Revenue | 2,828 | 2,299 | 3,096 | 2,584 | 3,410 | 4,732 |
Gross Profit | 453.65 | 361 | 387.92 | 367.21 | 204.91 | 485.4 |
Selling, General & Admin | 170.32 | 168.1 | 164.21 | 155.75 | 135.02 | 194.36 |
Research & Development | 1.86 | 2.3 | 2.03 | 2.75 | 1.83 | 2.62 |
Operating Expenses | 172.18 | 170.4 | 166.24 | 160.19 | 136.95 | 199.08 |
Operating Income | 281.47 | 190.6 | 221.68 | 207.03 | 67.96 | 286.33 |
Interest Expense | -30.27 | -32.96 | -22.47 | -16.14 | -21.66 | -25.73 |
Interest & Investment Income | 45.74 | 62.85 | 41.73 | 33.38 | 61.33 | 11.84 |
Earnings From Equity Investments | - | 7.75 | 25.41 | 31.34 | 30.88 | 24.22 |
Currency Exchange Gain (Loss) | -3.21 | 7.49 | -0.58 | 11.45 | -0.53 | -0.36 |
Other Non Operating Income (Expenses) | 11.93 | 3.29 | 7.46 | 8.27 | 1.34 | 6.56 |
EBT Excluding Unusual Items | 305.67 | 239.02 | 273.24 | 275.32 | 139.32 | 302.85 |
Gain (Loss) on Sale of Investments | - | -13.23 | - | - | - | 5.48 |
Gain (Loss) on Sale of Assets | 0.3 | 28 | 0.01 | 0.21 | -0.17 | - |
Other Unusual Items | - | - | 0.01 | - | - | - |
Pretax Income | 305.96 | 253.8 | 273.25 | 275.52 | 139.15 | 308.33 |
Income Tax Expense | 58.14 | 50.86 | 66.07 | 67.11 | 33.14 | -14.13 |
Earnings From Continuing Operations | 247.83 | 202.94 | 207.18 | 208.41 | 106.01 | 322.46 |
Minority Interest in Earnings | -2.44 | -3.22 | -2.38 | -1.48 | -3.27 | -6.8 |
Net Income | 245.39 | 199.73 | 204.79 | 206.93 | 102.74 | 315.65 |
Net Income to Common | 245.39 | 199.73 | 204.79 | 206.93 | 102.74 | 315.65 |
Net Income Growth | 21.14% | -2.47% | -1.03% | 101.41% | -67.45% | 79.93% |
Shares Outstanding (Basic) | 204 | 204 | 204 | 205 | 206 | 207 |
Shares Outstanding (Diluted) | 207 | 206 | 206 | 208 | 208 | 210 |
Shares Change (YoY) | 0.20% | -0.05% | -0.70% | 0.08% | -0.89% | -0.47% |
EPS (Basic) | 1.20 | 0.98 | 1.00 | 1.01 | 0.50 | 1.53 |
EPS (Diluted) | 1.19 | 0.97 | 0.99 | 1.00 | 0.49 | 1.51 |
EPS Growth | 21.39% | -2.02% | -1.00% | 104.00% | -67.52% | 80.46% |
Free Cash Flow | 2,425 | 373.22 | 1,233 | 396.76 | 543.21 | 782.95 |
Free Cash Flow Per Share | 11.74 | 1.81 | 5.97 | 1.91 | 2.62 | 3.74 |
Dividend Per Share | 0.500 | 0.500 | 0.392 | 0.385 | 0.240 | 0.769 |
Dividend Growth | 27.49% | 27.49% | 2.00% | 60.01% | -68.75% | 59.99% |
Gross Margin | 13.83% | 13.57% | 11.13% | 12.44% | 5.67% | 9.30% |
Operating Margin | 8.58% | 7.17% | 6.36% | 7.01% | 1.88% | 5.49% |
Profit Margin | 7.48% | 7.51% | 5.88% | 7.01% | 2.84% | 6.05% |
Free Cash Flow Margin | 73.90% | 14.03% | 35.38% | 13.44% | 15.03% | 15.01% |
EBITDA | 288.32 | 196.84 | 227.41 | 212.41 | 73.01 | 292.21 |
EBITDA Margin | 8.79% | 7.40% | 6.53% | 7.20% | 2.02% | 5.60% |
D&A For EBITDA | 6.85 | 6.23 | 5.73 | 5.38 | 5.05 | 5.88 |
EBIT | 281.47 | 190.6 | 221.68 | 207.03 | 67.96 | 286.33 |
EBIT Margin | 8.58% | 7.17% | 6.36% | 7.01% | 1.88% | 5.49% |
Effective Tax Rate | 19.00% | 20.04% | 24.18% | 24.36% | 23.82% | - |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.